Ramino-Bio

Oral drug for treating cardio-metabolic disease and rare MSUD

Active Seed Startup Founded 2018-09

Website ↗ LinkedIn

Ramino Bio is developing an oral drug to treat cardio-metabolic diseases and rare Maple Syrup Urine Disease (MSUD). Ramino Bio’s unique technology addresses the unmet need of several metabolic diseases in the emerging novel elevated BCAA (Branched-chain amino acid) field. With a druggable lead compound, showing efficacy in-vivo, Ramino Bio is heading precli…